BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 361103)

  • 1. [Nonspecific suppressive effect of Ehrlich tumor ascitic fluid on transplantation immunity].
    Belokhvostov AS; Zelenkova NK
    Biull Eksp Biol Med; 1978 Oct; 86(10):474-6. PubMed ID: 361103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance of ascitic fluid immunosuppressive factor DNA to pancreatic deoxyribonuclease].
    Belokhvostov AS; Zelenkova NK
    Biokhimiia; 1979 Apr; 44(4):711-4. PubMed ID: 435581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor(s) from Ehrlich Ascites cells responsible for delayed rejection of skin allografts in mice and its assay on lymphocytes in vitro.
    Gresser I; Vignaux F; Maury C; Lindahl P
    Proc Soc Exp Biol Med; 1975 May; 149(1):83-8. PubMed ID: 1096161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different behaviour of thymus in hosts bearing skin homografts or ehrlich ascites carcinoma.
    Simu G; Kiricuţă I; Crivii MS; Nestor D
    Arch Geschwulstforsch; 1976; 46(3):183-6. PubMed ID: 9920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the survival of skin grafts from normal mice and mice with Ehrlich ascites tumor.
    Hur NB; Biran S; Robinson E
    Transplantation; 1966 Mar; 4(2):205-6. PubMed ID: 5326924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gallium sulfate and skin allografts in the mouse].
    Maurel E; Mazard AM; Bouissou H
    Pathol Biol (Paris); 1976 May; 24(5):349-54. PubMed ID: 781603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
    Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
    [No Abstract]   [Full Text] [Related]  

  • 13. Further studies on the influence of calf alpha-globulin on survival of skin allografts in mice.
    Krzywicka E; Skopińska E; Wasik M; Tupalska B; Zaleska-Rutczyńska Z
    Arch Immunol Ther Exp (Warsz); 1976; 24(3):391-4. PubMed ID: 60986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of the synthetic immunomodulator, muramyl dipeptide, on rejection of mouse skin allografts.
    Zídek Z; Capková J; Boubelík M; Masek K
    Eur J Immunol; 1983 Oct; 13(10):859-61. PubMed ID: 6357810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H-thymidine incorporation into the DNA of the nucleic factor in the ascitic fluid of Ehrlich cancer].
    Belokhvostov AS
    Eksp Onkol; 1985; 7(6):50-3. PubMed ID: 4085399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cimetidine does not accelerate skin graft rejection in mice.
    Festen HP; Berden JH; Koene RA
    Clin Exp Immunol; 1980 Apr; 40(1):193-6. PubMed ID: 6993076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood ammonia in mice bearing Ehrlich ascites tumors].
    Carrascosa JM; Martínez P; Núñez de Castro I
    Rev Esp Fisiol; 1982; 38 Suppl():195-8. PubMed ID: 7146577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of first and second-set skin allografts in mice and rats under the influence of cysteine.
    Ryzewski J; Kossakowska M
    Arch Immunol Ther Exp (Warsz); 1974; 22(5):625-8. PubMed ID: 4614758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.